Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Fulgent Genetics, Inc. Director's Dealing 2019

Nov 13, 2019

32553_dirs_2019-11-12_f04493d1-b709-4c0a-9a15-6e683d84ac22.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2019-11-11

Reporting Person: KIM PAUL (CFO and Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-11-11 Common stock F 1326 $15.82 Disposed 439896 Direct

Footnotes

F1: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 10, 2016.